Ethics. Research. Community.

Blogging Ethics

Note: blog content is not currently included in EthicShare's Search Results.

06/20/2017 - 7:57pm

Exciting new research is revealing that psychedelic drugs, such as psilocybin and MDMA, may offer significant benefit for patients struggling at the end of life and those beset by major depressions and treatment-resistant post-traumatic stress. 

Confirmed speakers include:...

06/20/2017 - 7:57pm

Exciting new research is revealing that psychedelic drugs, such as psilocybin and MDMA, may offer significant benefit for patients struggling at the end of life and those beset by major depressions and treatment-resistant post-traumatic stress. 

A conference at the University of Washington School of Law, on October 27, 2017, brings together doctors, scientific researchers, attorneys and ethicists to consider the medical, legal and ethical implications of this evolving research.

Confirmed speakers include:

  • Dan Abrahamson, Senior Legal Advisor, Drug Policy Alliance's Office of Legal Affairs, Oakland, CA
  • Ira Byock, M.D., Founder and Chief Medical Officer, Providence Institute for Human Caring, Torrance, CA
  • Rick Doblin, Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies, Boston, MA
  • Representative Roger Goodman, Washington State Legislature, Kirkland, WA
  • Sam Kamin, marijuana law reform expert and Slate series author of “Altered States: Inside Colorado’s Marijuana Economy,” Professor of Law, University of Denver, Denver, CO
  • Patricia Kuszler, Charles I. Stone Professor of Law, University of Washington School of Law, Seattle, WA
  • Don Lattin, award-winning author and journalist, author of Changing our Minds—Psychedelic Sacraments and the New Psychotherapy, adjunct faculty, Graduate School of Journalism, University of California at Berkeley, CA
  • Lynn Mehler, partner, Hogan Lovells, Pharmaceutical and Biotechnology practice, Washington, DC
  • Leanna Standish, Ph.D., School of Naturopathic Medicine, Bastyr University, Seattle, WA
  • Kathryn Tucker, Executive Director, End of Life Liberty Project

06/20/2017 - 3:48pm

by Craig Klugman, Ph.D.

Despite campaign promises that drug prices would be lowered, the current administration and Congress seem on target for giving pharmaceutical companies more power over pricing, over keeping out competition and over expanding their monopolies. The President’s “Drug Pricing Innovation Working Group” is staffed by many current and former industry lobbyists. While the federal government is deliberating, some states are already acting.

Last week, Nevada passed a law that requires pharmaceutical manufacturers to disclose the prices, profits, and discounts of insulin.…

06/20/2017 - 12:57pm

“Compost bin. Pig trough. Dog-food bowl. Laptop keyboard.”

06/20/2017 - 12:47pm

Traditional flush toilets aren’t an option in many parts of the world, but neither is leaving people with unsafe and unhygenic choices. Now, one company is piloting a new loo that's waterless, off-grid and able to charge your phone. Lina Zeldovich travels to Madagascar to witness the start of a lavatorial revolution

06/20/2017 - 10:20am
It has been some time since my last posting. Of course, this is not due to their being a shortage of bioethics challenges related to developing countries. There is never a shortage of that. Rather, a number of research and training projects have pulled me away from my usual late night musings. I will get back to it. Fortunately, there is also some help on the way. Gaelen Snell is currently finishing off his Bachelor of Science degree (History and Philosophy of Science plus pre-med studies) at the University of British Columbia, Vancouver, Canada. This comes on top of his Bachelor of Art in Political Science obtained at the L'Institut d'Etudes Politiques de Paris. Gaelen has long been interested in health promotion in resource poor settings (including those located within the ‘developed world’) and is planning a career in humanitarian medicine. Gaelen will be contributing posts to this blog from time to time, as the spirit moves him.  Welcome Gaelen!
06/20/2017 - 9:40am

By Shannon Tapia My husband the Anesthesiologist came home one evening solemn, affected, not himself.  His patient died in the recovery room.  It was sudden, unexpected for my husband, and despite the team’s swift efforts and perfectly executed code, the patient died anyway.  It’s relevant to note that his patient was an almost 90 year […]

06/20/2017 - 9:30am

In the summer of 2015, Alexandra Franco got a letter in the mail from a company she had never heard of called AcurianHealth. The letter, addressed to Franco personally, invited her to participate in a study of people with psoriasis, a condition that causes dry, itchy patches on the skin

06/20/2017 - 9:19am

Marshall Allen: After I was prescribed a brand-name drug I didn’t need and given a coupon to cover the out-of-pocket costs, I discovered another reason Americans pay too much for health care.

06/20/2017 - 8:01am

In January 2017, clinicians at Great Ormond Street Hospital determined that continued life-sustaining medical treatment for Charlie Gard was not in his best interest.

...